as on November 19, 2025 at 2:29 am IST
Day's Low
Day's High
3.70%
Downside
0.93%
Upside
52 Week's Low
52 Week's High
57.41%
Downside
311.11%
Upside
Check Novabay Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$137.4M
EPS (TTM)
0Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0.21
Industry PE ratio
0PEG Ratio
0EBITDA
-5.1M
Revenue (TTM)
10.3M
Profit Margin
31.48%
Return On Equity TTM
-516.26%
Track how Novabay Pharmaceuticals Inc P/E has moved over time to understand its valuation trends.
Novabay Pharmaceuticals Inc in the last 5 years
Lowest (-130.24x)
June 30, 2021
Industry (0.00x)
November 19, 2025
Today (0.21x)
November 19, 2025
Highest (-0.23x)
March 31, 2025
Today’s Price to Earnings Ratio: 0.21x
Compare market cap, revenue, PE, and other key metrics of Novabay Pharmaceuticals Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $137.4M | -99.85% | 0.21 | 31.48% | |
| BUY | $60.8B | 273.39% | 1439.19 | 1.36% | |
| NA | $41.7B | NA | 710.62 | 1.38% | |
| BUY | $111.3B | 105.46% | 30.59 | 31.35% | |
| BUY | $74.6B | 40.92% | 16.89 | 32.13% |
The Novabay Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Novabay Pharmaceuticals Inc investment value today
Current value as on today
₹1,59,341
Returns
₹59,341
(+59.34%)
Returns from Novabay Pharmaceuticals Inc Stock
₹54,286 (+54.29%)
Dollar Returns*
₹5,056 (+5.06%)
Based on 6 analysts
83.33%
Buy
16.67%
Hold
0.00%
Sell
Based on 6 analysts, 83.33% of analysts recommend a 'BUY' rating for Novabay Pharmaceuticals Inc. Average target price of $0.85
Get share price movements and forecasts by analysts on Novabay Pharmaceuticals Inc.
What analysts predicted
-27.06%DOWNSIDE
Target Price
$0.85
Current Price
$1.08
Analyzed by
6 Analysts
Target
$0.85
Novabay Pharmaceuticals Inc target price $0.85, a slight downside of -27.06% compared to current price of $1.08. According to 6 analysts rating.
Search interest for Novabay Pharmaceuticals Inc Stock has decreased by -46% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 3 months, NBY stock has moved up by 81.7%
Profit Spike
![]()
Netprofit is up for the last 2 quarters, -1.92M → -1.29M (in $), with an average increase of 48.7% per quarter
Against Peers
![]()
In the last 1 year, Beone Medicines Ltd has given 100.6% return, outperforming this stock by 44.8%
Against Peers
![]()
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 85.4% return, outperforming this stock by 183.9%
Revenue Fall
![]()
Revenue is down for the last 4 quarters, 2.44M → 521.0K (in $), with an average decrease of 27.6% per quarter
| Organisation | Novabay Pharmaceuticals Inc |
| Headquarters | 2000 Powell Street, Emeryville, CA, United States, 94608 |
| Industry | Health Technology |
| CEO | Michael Kazley |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Tommy Law | Controller, Interim CFO & Treasurer |
Michael Kazley | CEO & Director |
Novabay Pharmaceuticals Inc share price today is $1.08 as on at the close of the market. Novabay Pharmaceuticals Inc share today touched a day high of $1.09 and a low of $1.04.
Novabay Pharmaceuticals Inc share touched a 52 week high of $4.44 on and a 52 week low of $0.46 on . Novabay Pharmaceuticals Inc stock price today i.e. is closed at $1.08,which is 75.68% down from its 52 week high and 134.78% up from its 52 week low.
Novabay Pharmaceuticals Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Novabay Pharmaceuticals Inc (NBY) shares with as little as ₹88.583 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹885.83 in Novabay Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Novabay Pharmaceuticals Inc share’s latest price of $1.08 as on November 19, 2025 at 2:29 am IST, you will get 9.2593 shares of Novabay Pharmaceuticals Inc. Learn more about
fractional shares .
Novabay Pharmaceuticals Inc stock has given -99.85% share price returns and 19.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?